In a major step forward for sunscreen science, the Double Plate Method (DPM) has just been recognized as an official ISO standard (ISO 23675:2024). This fully in vitro SPF testing method, developed by experts at Cosmetics Europe, marks a pivotal shift in how sun protection efficacy can be measured without exposing human volunteers to harmful UV radiation.

What is the Double Plate Method?

The DPM is a laboratory-based method that uses two polymer plates designed to mimic the texture and topography of human skin. These plates are coated with sunscreen by a robot to ensure consistency and then analyzed using a spectrophotometer to measure UV absorbance. This removes the variability introduced by human application and assessment, which has long been a limitation of traditional in vivo testing.

Why It Matters

Until now, the gold standard for measuring Sun Protection Factor (SPF) was an in vivo method (ISO 24444:2019) that required testing on human skin, including inducing erythema (sunburn) to assess product performance. The DPM eliminates this need entirely. Not only is this a major ethical improvement, but it also improves reproducibility, reliability, and cost-effectiveness.

Key Advantages of the DPM

  • Ethical innovation: No human volunteers are required, removing the need to expose skin to damaging UVB rays.

  • Reproducible results: Automated application and standardized testing provide consistent outcomes across labs and testing runs.

  • Year-round testing: Unlike in vivo methods that require untanned skin, the DPM can be used any time of year.

  • Validated accuracy: Hundreds of products have shown strong correlation between DPM and traditional SPF testing results.

  • Cost-effective: While robotic equipment is an upfront investment, the method reduces long-term costs for manufacturers.

A Win for Science and Consumer Safety

The DPM aligns with the European Commission’s long-standing recommendation to favor in vitro sunscreen testing methods for UVA and UVB protection. By eliminating human subjectivity and variability, it offers a more objective path to SPF validation. As this method becomes more widely adopted, consumers can expect more accurate labeling and safer sun protection standards worldwide.

author avatar
Dr. Jane Yoo Board-Certified Dermatologist and Mohs Surgeon
Jane Yoo, MD, MPP, is a Korean American board-certified dermatologist and fellowship-trained Mohs surgeon based in Midtown Manhattan. She is a Clinical Assistant Professor at the Icahn School of Medicine at Mount Sinai and the founder of Jane Yoo MD, PLLC and the Clinical Research Center of New York. Dr. Yoo holds an undergraduate degree from MIT and a Masters of Public Policy from Harvard's Kennedy School of Government. She completed her Mohs micrographic surgery fellowship at Yale. Her clinical and research focus spans aesthetic clinical trials including injectables and laser technology, skincare formulation and sunscreen science, K-Beauty and skin of color, ultrasound guided filler dissolution, artificial intelligence and beauty tech. Dr. Yoo's research is indexed under ORCID 0000-0002-7112-8963.